WebbPropstack Website Propstack > Kunden-Support Kunden-Support Wir bieten Ihnen einen Live-Chat Support an, um Ihre Probleme schnellstmöglich zu lösen Produkt Warum … WebbPropstack Das sagen Nutzer über Propstack Finden Sie mehr Informationen zu Propstack Preise, Erfahrungen, Funktionen und Bewertungen im Überblick. Propstack: Bewertungen, Preise und Features - Softwareabc24
Was ist die beste Immobilienmakler Software? - 11+ Tools - Digital …
WebbPropmodo January 3, 2024 Real estate technology (PropTech) investment soared in 2024. Based on data from CB Insights, global funding for PropTech companies may have reached $3 billion for the year.... WebbPropstack is India's leading Real Estate data, analytics and workflow solutions platform and was developed in response to a need for greater market transparency. ... Get in touch with our help desk. Reach us +91 865 242 4358 ; [email protected] (New users) [email protected] (Existing users) Our offices . cost based reimbursement advantages
REAL ESTATE DATA - The Economic Times
WebbDeveloper of a software service to help companies keep tabs on their competitors. The company develops a software that aggregates blog posts and web traffic data in order to provide the competitive information, and all of it is condensed to allow different members of a subscribing company to update the data and provide their own interpretations. WebbPropstack ist seit dem ersten Tag inhabergeführt, selbstfinanziert und kommt ohne die Interessen Dritter aus. Damit sind wir unabhängig und können uns voll auf unser Produkt und unsere Kunden konzentrieren. Unsere Meilensteine 2013 Umsetzung der Idee einer zukunfts- und cloudbasierten Maklersoftware, made in Berlin 2014 Webb6 feb. 2024 · "We are excited with this investment from these strategic investors and believe that it’ll help accelerate the adoption and development of our platform with the help of industry leaders who believe in our ability to deliver real innovation to real estate," said Raja Seetharaman, co-founder & director of Propstack. cost based reimbursement medicare